| Tamro Sweden
Total pharmaceutical sales for the period February–October
2007 were EUR 2,286 million in pharmacy purchase
prices (PPP), which represents growth of 7%
at constant exchange rates (CER) compared to
last year. During the first nine months of this
reporting period the net sales of Tamro Sweden
increased to EUR 1278 (1255) million. Tamro’s
average market share for February–October
remained at 53%.
Tamro Sweden’s share of the Group’s
net sales remained at 31%, and the company employed
an average of 445 (443) people.
The enquiry concerning the liberalisation of
the Swedish pharmacy markets is still ongoing
and the recommendation is expected to be ready
in early January 2008, targeting an implementation
as from 1 January 2009. The commission working
on these proposals has already announced that
it will suggest free establishment of new pharmacies,
permit vertical integration and multiple ownership.
It is being recommended, also by the current
state monopoly Apoteket AB, that Apoteket shall
sell out a majority of their pharmacies to reach
a more moderate (and non-dominant) market position,
if this is what is needed to be granted freedom
to act commercially in the market.
The authorities in Sweden have also presented
a legislative bill for deregulating the nicotine
treatment products. It is proposed that the
bill will take effect as of 1 March 2008. Recommendations
for a comprehensive OTC liberalisation will
be presented during the spring.
|
